Paul Tudor Jones Dynavax Technologies Corp Transaction History
Tudor Investment Corp Et Al
- $44 Billion
- Q2 2025
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 59,925 shares of DVAX stock, worth $623,220. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59,925
Previous 48,467
23.64%
Holding current value
$623,220
Previous $628,000
5.41%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding DVAX
# of Institutions
293Shares Held
120MCall Options Held
294KPut Options Held
86.1K-
Black Rock Inc. New York, NY21.9MShares$228 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$185 Million6.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$87.6 Million0.0% of portfolio
-
State Street Corp Boston, MA6.4MShares$66.5 Million0.0% of portfolio
-
Chicago Capital, LLC4.31MShares$44.8 Million1.06% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.32B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...